Dror Bashan serves as Executive at Protalix BioTherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Dror Bashan has executed 10 insider transactions totaling $293.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 19, 2025 involved purchasing 56,000 shares valued at $101.4K.
Dror Bashan currently holds 188,516 shares of Protalix BioTherapeutics, Inc. (PLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dror Bashan has been a net buyer of PLX stock. They have purchased $293.8K and sold $0 worth of shares.
Dror Bashan's most recent insider trade was on Dec 19, 2025, when they purchased 56,000 shares at $1.81 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 1, 2024 | PLX | $0 | Award | 263,960 | $N/A | Discretionary |
| Oct 19, 2023 | PLX | $67.7K | Purchase | 48,387 | $1.40 | Discretionary |
| Oct 19, 2023 | PLX | $22.7K | Purchase | 16,129 | $1.41 | Discretionary |
| Aug 15, 2023 | PLX | $0 | Award | 800,000 | $N/A | Discretionary |
| Apr 11, 2022 | PLX | $102.0K | Purchase | 68,000 | $1.50 | Discretionary |
| Feb 25, 2022 | PLX | $0 | Award | 637,531 | $N/A | Discretionary |
| Aug 11, 2020 | PLX | $0 | Award | 447,927 | $N/A | Discretionary |
| Aug 11, 2020 | PLX | $0 | Award | 447,927 | $N/A | Discretionary |